IL155706A0 - Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole - Google Patents

Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole

Info

Publication number
IL155706A0
IL155706A0 IL15570601A IL15570601A IL155706A0 IL 155706 A0 IL155706 A0 IL 155706A0 IL 15570601 A IL15570601 A IL 15570601A IL 15570601 A IL15570601 A IL 15570601A IL 155706 A0 IL155706 A0 IL 155706A0
Authority
IL
Israel
Prior art keywords
benzenesulfonylethyl
methylpyrrolidin
ylmethyl
indole
preparation
Prior art date
Application number
IL15570601A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL155706A0 publication Critical patent/IL155706A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL15570601A 2000-12-20 2001-12-06 Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole IL155706A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031094.6A GB0031094D0 (en) 2000-12-20 2000-12-20 New Process
PCT/IB2001/002338 WO2002050063A1 (en) 2000-12-20 2001-12-06 New process

Publications (1)

Publication Number Publication Date
IL155706A0 true IL155706A0 (en) 2004-02-19

Family

ID=9905487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15570601A IL155706A0 (en) 2000-12-20 2001-12-06 Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole

Country Status (20)

Country Link
EP (1) EP1373254B1 (xx)
JP (1) JP2004516290A (xx)
KR (1) KR20030061448A (xx)
CN (1) CN1199969C (xx)
AR (2) AR035406A1 (xx)
AT (1) ATE308539T1 (xx)
AU (1) AU2002218440A1 (xx)
BR (1) BR0116324A (xx)
CA (1) CA2432138C (xx)
CZ (1) CZ20031640A3 (xx)
DE (1) DE60114668T2 (xx)
ES (1) ES2249386T3 (xx)
GB (1) GB0031094D0 (xx)
HU (1) HUP0302465A2 (xx)
IL (1) IL155706A0 (xx)
MX (1) MXPA03005569A (xx)
PL (1) PL362716A1 (xx)
RU (1) RU2256660C2 (xx)
WO (1) WO2002050063A1 (xx)
ZA (1) ZA200303446B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
WO2008137134A2 (en) * 2007-05-01 2008-11-13 Teva Pharmaceuticals Usa, Inc. Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
IT1393700B1 (it) * 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011024039A1 (en) * 2009-08-25 2011-03-03 Ramesh Babu Potluri Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives
WO2011089614A1 (en) 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2012004811A1 (en) * 2010-07-06 2012-01-12 Ind-Swift Laboratories Limited Process for the preparation of 5-substsituted indole derivative
JP2019502761A (ja) 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ （（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法
CN112440631B (zh) * 2020-11-02 2022-09-13 长城汽车股份有限公司 一种调节胎压装置、方法、系统以及车辆

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0179053B1 (ko) * 1990-10-15 1999-03-20 알렌 제이.스피겔 인돌 유도체

Also Published As

Publication number Publication date
EP1373254B1 (en) 2005-11-02
AU2002218440A1 (en) 2002-07-01
CA2432138A1 (en) 2002-06-27
GB0031094D0 (en) 2001-01-31
ATE308539T1 (de) 2005-11-15
BR0116324A (pt) 2003-10-14
CN1199969C (zh) 2005-05-04
EP1373254A1 (en) 2004-01-02
HUP0302465A2 (hu) 2003-12-29
AR035406A1 (es) 2004-05-26
DE60114668D1 (de) 2005-12-08
CN1487932A (zh) 2004-04-07
CA2432138C (en) 2007-05-08
AR043016A2 (es) 2005-07-13
ES2249386T3 (es) 2006-04-01
WO2002050063A1 (en) 2002-06-27
MXPA03005569A (es) 2003-10-06
DE60114668T2 (de) 2006-07-20
PL362716A1 (en) 2004-11-02
JP2004516290A (ja) 2004-06-03
RU2256660C2 (ru) 2005-07-20
ZA200303446B (en) 2004-07-05
KR20030061448A (ko) 2003-07-18
CZ20031640A3 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
MXPA03001001A (es) Derivados anticonvulsionantes utiles para el tratameinto de la depresion.
IL143979A0 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
AU2001272852A1 (en) Composition for the treatment of migraine
IL158693A0 (en) Azole compounds, process for preparation of the same and use thereof
AU2000276362A1 (en) Composition for the treatment of diabetes
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
MXPA03000585A (es) Proceso de fermentacion para la preparacion de l-treonina.
AU8322401A (en) Indole compounds useful for the treatment of cancer
IL155706A0 (en) Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
MXPA01002595A (es) Mordaza para componentes de intrerconexion de aparatos de apuntalamiento.
MXPA03002464A (es) Proceso para preparar benzotriazoles.
IL148640A0 (en) Processes for the preparation of sumatriptan and related compounds
MXPA02006102A (es) Metodo para preparar compuestos bormodifluoroaceticos.
HK1059782A1 (en) Indole derivatives useful for the treatment of cnsdisorders
AU8824201A (en) Process for the preparation of dinapsoline
AU2827100A (en) Process for the preparation of phenylhydrazines
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
MXPA03007624A (es) Procedimiento para la preparacion de (e)-5-(2-bromovinil)-2-desoxiuridina.
ZA200101529B (en) Process for the preparation of isoindoline.